OnKure Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
OnKure Therapeutics Total Assets Growth & History (OKUR)
OnKure Therapeutics's total assets was $62.1M for fiscal 2025.
View full OnKure Therapeutics company overviewOnKure Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $62.1M | −$52.8M | −45.94% |
| 2024 | 2024-12-31 | $114.9M | $79.2M | +221.56% |
| 2023 | 2023-12-31 | $35.7M | −$72.4M | −66.97% |
| 2022 | 2022-12-31 | $108.2M | −$45.8M | −29.76% |
| 2021 | 2021-12-31 | $154.0M | $98.8M | +178.92% |
| 2020 | 2020-12-31 | $55.2M | — | — |
OnKure Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $179.4M | $93.3M | +108.38% |
| Q1 2026 | 2026-03-31 | $198.7M | $98.8M | +98.93% |
| Q4 2025 | 2025-12-31 | $62.1M | −$52.8M | −45.94% |
| Q3 2025 | 2025-09-30 | $72.8M | −$4.8M | −6.19% |
| Q2 2025 | 2025-06-30 | $86.1M | $7.4M | +9.34% |
| Q1 2025 | 2025-03-31 | $99.9M | $15.2M | +18.01% |
| Q4 2024 | 2024-12-31 | $114.9M | $79.2M | +221.56% |
| Q3 2024 | 2024-09-30 | $77.6M | −$52.7M | −40.45% |
| Q2 2024 | 2024-06-30 | $78.7M | −$69.3M | −46.83% |
| Q1 2024 | 2024-03-31 | $84.6M | −$14.2M | −14.39% |
| Q4 2023 | 2023-12-31 | $35.7M | −$72.4M | −66.97% |
| Q3 2023 | 2023-09-30 | $130.4M | $7.9M | +6.44% |
| Q2 2023 | 2023-06-30 | $148.0M | $14.4M | +10.80% |
| Q1 2023 | 2023-03-31 | $98.9M | −$45.5M | −31.54% |
| Q4 2022 | 2022-12-31 | $108.2M | −$45.8M | −29.76% |
| Q3 2022 | 2022-09-30 | $122.5M | −$40.4M | −24.82% |
| Q2 2022 | 2022-06-30 | $133.6M | −$37.7M | −22.01% |
| Q1 2022 | 2022-03-31 | $144.4M | $49.1M | +51.50% |
| Q4 2021 | 2021-12-31 | $154.0M | $98.8M | +178.92% |
| Q3 2021 | 2021-09-30 | $162.9M | — | — |
| Q2 2021 | 2021-06-30 | $171.3M | — | — |
| Q1 2021 | 2021-03-31 | $95.3M | — | — |
| Q4 2020 | 2020-12-31 | $55.2M | — | — |
OnKure Therapeutics total assets trends
Over the last five fiscal years, OnKure Therapeutics's total assets increased from $55.2M to $62.1M, a change of $6.9M. The latest reported quarter, Q2 2026, shows $179.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OnKure Therapeutics source filings ↗